Development of inhibitors of heterotrimeric G?i subunits.
Ontology highlight
ABSTRACT: Heterotrimeric G-proteins are the immediate downstream effectors of G-protein coupled receptors (GPCRs). Endogenous protein guanine nucleotide dissociation inhibitors (GDIs) like AGS3/4 and RGS12/14 function through GPR/Goloco GDI domains. Extensive characterization of GPR domain peptides indicate they function as selective GDIs for G?i by competing for the GPCR and G?? and preventing GDP release. We modified a GPR consensus peptide by testing FGF and TAT leader sequences to make the peptide cell permeable. FGF modification inhibited GDI activity while TAT preserved GDI activity. TAT-GPR suppresses G-protein coupling to the receptor and completely blocked ?2-adrenoceptor (?2AR) mediated decreases in cAMP in HEK293 cells at 100nM. We then sought to discover selective small molecule inhibitors for G?i. Molecular docking was used to identify potential molecules that bind to and stabilize the G?i-GDP complex by directly interacting with both G?i and GDP. G?i-GTP and G?q-GDP were used as a computational counter screen and G?q-GDP was used as a biological counter screen. Thirty-seven molecules were tested using nucleotide exchange. STD NMR assays with compound 0990, a quinazoline derivative, showed direct interaction with G?i. Several compounds showed G?i specific inhibition and were able to block ?2AR mediated regulation of cAMP. In addition to being a pharmacologic tool, GDI inhibition of G? subunits has the advantage of circumventing the upstream component of GPCR-related signaling in cases of overstimulation by agonists, mutations, polymorphisms, and expression-related defects often seen in disease.
SUBMITTER: Appleton KM
PROVIDER: S-EPMC4103618 | biostudies-literature | 2014 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA